| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |